评估甲基酸盐和莫达菲尼尔对大鼠抑制能力,时间估计,注意力缺失和强迫性行为的急性影响
Rodrigo Sosa1, Pedro Espinosa-Villafranca2, Pablo Saavedra3
1Universidad Panamericana, Escuela de Pedagogía y Psicología, Guadalajara, Mexico.
Behavioural pharmacology
|January 30, 2025
概括
认知增强剂甲基尼达和莫达菲尼尔在老鼠身上进行了测试. 莫达菲尼尔降低了性能,而甲基胺则显示了暂时的益处,这引发了对非标签使用的安全担忧.
科学领域:
- 神经科学是一个神经科学.
- 行为药理学行为药理学
背景情况:
- 认知增强剂越来越多地被健康人非标签使用.
- 这种非标签的使用引发了严重的安全问题.
研究的目的:
- 评估甲基酸盐和莫达菲尼尔在神经类型大鼠的行为影响.
- 评估这些认知增强剂对表现和停药期间的影响.
主要方法:
- 一个行为任务模拟认知要求的挑战,需要回应抑制奖励.
- 测量包括强迫性反应,冲动性,时间估计和注意力缺失.
- 鼠类接受了甲基化物,莫达菲尼尔或车辆控制.
主要成果:
- 莫达菲尼尔的使用降低了奖励获取和效率,与冲动性有关.
- 停用莫达菲尼尔后,表现部分恢复.
- 甲基酸在主要分析中没有显示出显著的影响,但探索性分析表明短期的好处.
结论:
- 莫达菲尼尔的非标签使用可能会损害认知表现并增加冲动性.
- 甲基酸的作用似乎是暂时的,并且依赖于剂量.
- 该研究强调了认知增强剂的潜在风险和成本效益考虑.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
01:30Attention-Deficit/Hyperactivity Disorder
36
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
36